Clinical Trials Directory

Trials / Completed

CompletedNCT04467476

Effects of tDCS on Anaerobic Power of Lower Limb Muscles

Effects of tDCS on Mechanical Power of the Leg Extensor Muscles of Healthy Subjects

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Universidade Federal do Piauí · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Anaerobic power and capacity are essential in many human activities, especially during sports practice that demand a high strength and power of the limbs. Transcranial direct current stimulation is a noninvasive technique that can modulate motor brain areas involved in motor functions and has the potential to optimize muscle capacity. However, their effects on mechanical power are lacking. This study aims to investigate the effects of transcranial direct current stimulation (tDCS) on mechanical power in healthy subjects.

Detailed description

In this study, a randomized, crossover, double-blind, placebo-controlled experimental design will be used. The 50 participants will be randomized into two groups: (1) Anodal tDCS(real) and (2) Sham tDCS. A single session of anodal and sham tDCS will be performed on each task (pre and post-jump test). All evaluations will be performed by a single researcher who, like the participants, will not know which stimulation group will be participating. Subjects who agree to the conditions and sign the consent form may participate in the study. Participants who meet the eligibility criteria will be included in the study.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial direct current stimulationTranscranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various health conditions. However, its ergogenic effect still has controversial results.

Timeline

Start date
2021-01-01
Primary completion
2021-02-28
Completion
2021-04-29
First posted
2020-07-13
Last updated
2021-05-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04467476. Inclusion in this directory is not an endorsement.